Respiratory syncytial virus vaccine development (Q56481283)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11587807 AND SRC:MED&resulttype=core&format=json

11 November 2019

title

Respiratory syncytial virus vaccine development (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11587807 AND SRC:MED&resulttype=core&format=json

11 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11587807 AND SRC:MED&resulttype=core&format=json

11 November 2019

1

James E. Crowe

0 references

language of work or name

English

0 references

publication date

1 October 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11587807 AND SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11587807 AND SRC:MED&resulttype=core&format=json

11 November 2019

volume

20 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11587807 AND SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

S32-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11587807 AND SRC:MED&resulttype=core&format=json

Respiratory syncytial virus infection in inbred mice

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Primary respiratory syncytial virus infection in mice

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Live subgroup B respiratory syncytial virus vaccines that are attenuated, genetically stable, and immunogenic in rodents and nonhuman primates

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Neonatal respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Passive protection against respiratory syncytial virus disease in infants: the role of maternal antibody.

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Immunity to and frequency of reinfection with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Relation of serum antibody to glycoproteins of respiratory syncytial virus with immunity to infection in children

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Pathogenesis of respiratory syncytial virus vaccine-augmented pathology

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Sequential annual administration of purified fusion protein vaccine against respiratory syncytial virus in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Safety and immunogenicity of a purified F protein respiratory syncytial virus (PFP-2) vaccine in seropositive children with bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60.

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Maternal immunization against viral disease

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Respiratory syncytial virus illnesses in human immunodeficiency virus- and noninfected children

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Group-specific serum antibody responses in children with primary and recurrent respiratory syncytial virus infections

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

The Immunologic Response to Infection with Respiratory Syncytial Virus in Infants

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for va

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Acquisition of the ts phenotype by a chemically mutagenized cold-passaged human respiratory syncytial virus vaccine candidate results from the acquisition of a single mutation in the polymerase (L) gene

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Nucleotide sequence analysis of the respiratory syncytial virus subgroup A cold-passaged (cp) temperature sensitive (ts) cpts-248/404 live attenuated virus vaccine candidate

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Effect of coexpression of interleukin-2 by recombinant respiratory syncytial virus on virus replication, immunogenicity, and production of other cytokines

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

A live attenuated recombinant chimeric parainfluenza virus (PIV) candidate vaccine containing the hemagglutinin-neuraminidase and fusion glycoproteins of PIV1 and the remaining proteins from PIV3 induces resistance to PIV1 even in animals immune to

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

A recombinant human parainfluenza virus type 3 (PIV3) in which the nucleocapsid N protein has been replaced by that of bovine PIV3 is attenuated in primates

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Human parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancy

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

A comparison in chimpanzees of the immunogenicity and efficacy of live attenuated respiratory syncytial virus (RSV) temperature-sensitive mutant vaccines and vaccinia virus recombinants that express the surface glycoproteins of RSV.

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Immunogenicity of recombinant adenovirus-respiratory syncytial virus vaccines with adenovirus types 4, 5, and 7 vectors in dogs and a chimpanzee

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Priming and boosting immunity to respiratory syncytial virus by recombinant replication-defective vaccinia virus MVA.

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia--RSV recombinants or RSV.

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in the institutionalized elderly

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Protection against respiratory syncytial virus infection by DNA immunization

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in Balb/c mice that are similar to those generated by experimental infection

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

Adjuvants influence the quantitative and qualitative immune response in BALB/c mice immunized with respiratory syncytial virus FG subunit vaccine

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)00287-0

7 January 2021

10.1016/S0264-410X(01)00287-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11587807 AND SRC:MED&resulttype=core&format=json

11 November 2019

1 reference